Amgen 20 abr 2026 Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
FierceBiotech 16 abr 2026 Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech 6 abr 2026 With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine
FierceBiotech 1 abr 2026 Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story
FierceBiotech 1 abr 2026 Oric chases Pfizer into phase 3 hailing prostate cancer edge, but investors send stock down
BioPharma Dive 23 mar 2026 Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results
FierceBiotech 23 mar 2026 Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
FierceBiotech 12 mar 2026 Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
Endpoints News 6 mar 2026 Pfizer gets obesity drug approval in China shortly after buying local rights